article thumbnail

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

GeekWire

Eby has been succeeded by Morgan Hellar who originally joined WRF in 2004 as a license administrator for the organization’s patent portfolio. Czerwiec was most recently chief medical officer at Goldfinch Bio and spent two decades at Otsuka Pharmaceutical. Chris Chin.

article thumbnail

Sneaky synthetic molecules open the way for new types of drugs and a new startup

GeekWire

” Bhardwaj, Baker and UW biochemist Patrick Salveson — who are all associated with UW Medicine’s Institute for Protein Design — have co-founded a new biotech company called Vilya with Arch Venture Partners to license the platform and the molecules described in the Cell paper.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alpine Immune Sciences stock rises after biotech firm lands $60M from AbbVie for lupus drug

GeekWire

Alpine Immune Sciences stock rose more than 10% Friday after the Seattle-based biotech company inked a $60 million licensing deal with pharmaceutical giant AbbVie for its lupus drug.

article thumbnail

Ireland’s status as tax haven for tech firms like Google, Facebook, and Apple is ending

The Verge

This is a major shift for the country that is the European headquarters for many large US pharmaceutical companies, as well as tech firms, including Google, Apple, and Facebook. Google in Dublin | Photo by Artur Widak/NurPhoto via Getty Images.

article thumbnail

Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing

GeekWire

Where scheduling is involved, we always stay within the bounds of labs that are licensed for handling.” The company has four employees and plans to hire experts in advanced drug development and pharmaceutical regulatory processes.

Chemicals 144
article thumbnail

Univ. of Wash.-spinout Icosavax raises $100M to fund vaccine development technology

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. Icosavax Photo).

article thumbnail

Seattle startup claims India-based drugmaker stole COVID-19 vaccine tech, seeks $950M

GeekWire

The complaint, filed Monday in federal court in Seattle, asks for at least $950 million in damages from Emcure Pharmaceuticals , and an order banning its use of HDT’s technology. The License Agreement, which is the subject matter of the suit, is between Gennova and HDT.

article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. Founder and CEO Adam Simpson formerly led another IPD spinout, PvP Biologics, which sold to the pharmaceutical company Takeda.

article thumbnail

Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants

GeekWire

The startup is planning similar licensing deals with other companies that will be announced later this year, Salk said. Chief Operating Officer Elena Cant joined the company in January 2020 and was most recently at Takeda Pharmaceuticals.

article thumbnail

Alpine raises $91M to fuel the Seattle biotech’s clinical trials for lupus and cancer

GeekWire

That payment is part of a licensing deal inked last year with the pharmaceutical giant for clinical testing of another immune-modulating agent, ALPN-101, for lupus. Alpine’s pipeline. Alpine Graphic).

article thumbnail

Impel NeuroPharma, fresh off IPO, gets FDA approval for nasal spray that treats migraines

GeekWire

It’s been a “big challenge to shift from a device technology-focused company to what is now a pretty integrated pharmaceutical company,” said Hoekman. Impel’s POD technology delivers drugs deep into the nasal cavity for the treatment of migraine headaches. Impel Photo). The U.S.

article thumbnail

Merck’s multi-billion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

GeekWire

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. Seattle Genetics CEO Clay Siegall. Seattle Genetics Photo).

article thumbnail

Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to treat solid tumors

GeekWire

Knowles was previously CEO of Exonics Therapeutics, which was acquired by Vertex Pharmaceuticals for $245 million. Meanwhile, CRISPR gene editing technology licensed from other sources enhances the platform capabilities.

article thumbnail

Neuralink shows what happens when you bring “move fast and break things” to animal research

Vox

The USDA can impose severe penalties against other enterprises governed by the Animal Welfare Act, including criminal charges , confiscating animals , revoking or suspending licenses , or applying for injunctions. Christina Animashaun/Vox; Getty Images.

article thumbnail

Ex-Athira Pharma CEO Leen Kawas starts $150M fund with key investors from former company

GeekWire

Papers with altered images were cited in an earlier patent licensed by the company from WSU. Laursen , a pharmaceutical and biotechnology executive; Sylvia S.

article thumbnail

Rep. Pramila Jayapal on vaccine equity, misinformation, preparing for the next pandemic

GeekWire

to come out firmly for the TRIPS [intellectual property] waivers so that we could license these vaccines around the globe, wherever there was capacity, and make sure that we could produce them in other countries. Pramila Jayapal (left) and Umair Shah, Washington state secretary of health.

article thumbnail

AI suggested 40,000 new possible chemical weapons in just six hours

The Verge

He’s also a senior scientist at Collaborations Pharmaceuticals, Inc.,

Chemicals 145
article thumbnail

Why the global chip shortage is making it so hard to buy a PS5

The Verge

So you buy a processing unit design from somebody like Arm in the UK, who is very popular, and then maybe you need the USB interface, so you get a USB IP block, which you license. Photo Illustration by Grayson Blackmon / The Verge.

Intel 134
article thumbnail

Value Networks Masterclass in New Zealand with Verna Allee - Trends in the Living Networks

Trends in the Living Networks

Examples included Cisco’s extended network, value flows in the pharmaceutical industry and an engineering firm, among others. Verna, working with Oliver Schwabe and others, has released a suite of Creative Commons-licensed open resources, tools, and applications for value networks analysis.

Network 63
article thumbnail

Enterprise Twitter – or how to tap social networks for expertise without using email - Trends in the Living Networks

Trends in the Living Networks

Executive Forum , one of the showcased companies, Janssen-Cilag, an Australian pharmaceutical subsidiary of Johnson & Johnson, gave us a snapshot of an internal tool they’ve developed called Jitter (see Nathan Wallace’s presentation and resources on his blog ), which is essentially Twitter for the enterprise.

Network 60
article thumbnail

Microsoft enters enterprise social network software - Trends in the Living Networks

Trends in the Living Networks

Each of these companies has developed fairly mature offerings, and gained traction in the corporate marketplace, with a number of leading audit firms, investment banks, and pharmaceutical companies in the process of implementing their software.

Network 60
article thumbnail

2021 Predictions: Why these tech, science and startup leaders are upbeat about the year ahead

GeekWire

Other bold predictions for 2021 in tech, politics, sports or anything else: We will see big investments and acquisitions in the biotech and pharmaceutical space in tech in 2021, as it becomes more obvious that AI is just about ready for prime time. And I’ll earn my A-class license on iRacing….

Sports 144
article thumbnail

The future of adult entertainment - Trends in the Living Networks

Trends in the Living Networks

Add a dose of pharmaceuticals - legal or illegal - and things could get very interesting. Incidentally, prior to the 1960s, pharmaceutical companies were not really involved with sex, but the contraceptive pill, HIV/AIDS and Viagra have changed that.

Trends 86
article thumbnail

Mark Cuban on America’s future

The Verge

Prior to 230, like when we were doing Broadcast.com and AudioNet, any piece of content that I have put on there, I had to have a license for it. They have to get a license before they put that on CNN, right? Photo illustration by William Joel / The Verge.

Sports 88